Location History:
- SE-174 48 Sundbyberg, SE (2010)
- Sundbyberg, SE (2006 - 2014)
Company Filing History:
2 out of 4 
2 out of 55 
1 out of 38 Years Active: 2006-2014
Title: Helena Lundström: Innovator in Therapeutic Compounds
Introduction
Helena Lundström is a prominent inventor based in Sundbyberg, Sweden. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that are therapeutically active in the central nervous system. With a total of five patents to her name, Lundström's work has the potential to impact the treatment of various serotonin-related disorders.
Latest Patents
Lundström's latest patents include two notable inventions. The first patent is for (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and its salts. This invention relates to a process for preparing compounds that are therapeutically active in the central nervous system. The compounds are designed to be used in the manufacture of medicaments for treating serotonin-related disorders. The second patent is for the malate salt of (2R)-methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine, which also focuses on the preparation of therapeutically active compounds for similar medical applications.
Career Highlights
Throughout her career, Lundström has worked with notable companies, including Biovitrum AB. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to innovate in the field of medicinal chemistry.
Collaborations
Lundström has collaborated with several professionals in her field, including Magnus Cernerud and Claes Löfström. These collaborations have likely contributed to her success and the advancement of her research.
Conclusion
Helena Lundström is a distinguished inventor whose work in therapeutic compounds has the potential to significantly benefit the medical community. Her innovative patents and collaborations highlight her commitment to advancing medicinal chemistry.